Talis Biomedical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	17	28	25	225	-
Market Cap Growth	-	12.49%	-88.79%	-	-
Enterprise Value	-41	-29	-71	7	-172
PE Ratio	-0.46	-0.46	-0.22	-1.17	-
PS Ratio	7.76	13.31	5.25	27.48	-
PB Ratio	0.24	0.41	0.20	0.96	-
P/FCF Ratio	-0.53	-0.53	-0.25	-1.29	-
P/OCF Ratio	-0.53	-0.53	-0.25	-1.31	-
EV/Sales Ratio	-13.43	-13.43	-14.83	0.81	-15.77
EV/EBITDA Ratio	0.50	0.50	0.70	-0.03	1.92
EV/EBIT Ratio	0.46	0.46	0.63	-0.03	1.89
EV/FCF Ratio	0.53	0.53	0.70	-0.04	1.81
Debt / Equity Ratio	0.28	0.28	0.26	0.06	-0.01
Debt / EBITDA Ratio	-0.35	-0.35	-0.33	-0.07	-0.01
Debt / FCF Ratio	-0.37	-0.37	-0.33	-0.08	-0.01
Quick Ratio	8.75	8.75	10.30	12.18	10.83
Current Ratio	8.86	8.86	10.52	12.36	11.77
Asset Turnover	0.02	0.02	0.02	0.02	0.10
Return on Equity (ROE)	-69.50%	-69.50%	-68.60%	-67.20%	140.50%
Return on Assets (ROA)	-54.20%	-54.20%	-55.40%	-56.80%	-81.30%
Return on Capital (ROIC)	-75.26%	-75.26%	-71.82%	-77.36%	84.53%
Earnings Yield	-374.59%	-218.34%	-447.63%	-85.28%	-
FCF Yield	-324.56%	-189.18%	-403.02%	-77.39%	-
Buyback Yield / Dilution	-0.95%	-0.95%	-19.21%	-968.49%	1.41%
Total Shareholder Return	-0.95%	-0.95%	-19.21%	-968.49%	1.41%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).